Human papillomavirus: Current prevalence and future protection

被引:26
作者
Bauer, Heidi M.
Ault, Kevin
机构
[1] Calif Dept Hlth Serv, Off Med & Sci Affairs, STD Control Branch, Richmond, CA 94804 USA
[2] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA
关键词
D O I
10.1097/01.olq.0000225323.51240.bc
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
引用
收藏
页码:509 / 511
页数:3
相关论文
共 32 条
[1]
*ADV COMM IMM PRAC, FEBR 2006 ACIP M PRE
[2]
*AM CANC SOC, OV CERV CANC
[3]
HPV communication: Review of existing research and recommendations for patient education [J].
Anhang, R ;
Goodman, A ;
Goldie, SJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (05) :248-259
[4]
The epidemiology of human papillomavirus infections [J].
Baseman, JG ;
Koutsky, LA .
JOURNAL OF CLINICAL VIROLOGY, 2005, 32 :S16-S24
[5]
*CDCP, 2004, MMWR-MORBID MORTAL W, V53, pSS2
[6]
Centers for Disease Control and Prevention, HUM PAP HPV INF
[7]
Davis Kristin, 2004, J Low Genit Tract Dis, V8, P188, DOI 10.1097/00128360-200407000-00005
[8]
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control [J].
Franco, EL ;
Harper, DA .
VACCINE, 2005, 23 (17-18) :2388-2394
[9]
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine [J].
Goldie, SJ ;
Kohli, M ;
Grima, D ;
Weinstein, MC ;
Wright, TC ;
Bosch, FX ;
Franco, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08) :604-615
[10]
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial [J].
Harper, DM ;
Franco, EL ;
Wheeler, C ;
Ferris, DG ;
Jenkins, D ;
Schuind, A ;
Zahaf, T ;
Innis, B ;
Naud, P ;
De Carvalho, NS ;
Roteli-Martins, CM ;
Teixeira, J ;
Blatter, MM ;
Korn, AP ;
Quint, W ;
Dubin, G .
LANCET, 2004, 364 (9447) :1757-1765